TEL AVIV, Israel, March 26, 2025 /PRNewswire/ — Neurim Pharmaceuticals (“Neurim”) announces that the European Commission has approved the extension of the indication to include the treatment of insomnia in children with attention deficit hyperactivity disorder (ADHD). The European…
Category: Uncategorized
TEL-AVIV, Israël, 26 mars 2025 /PRNewswire/ — Neurim Pharmaceuticals (« Neurim ») annonce que la Commission européenne a approuvé l’extension de l’indication pour inclure le traitement de l’insomnie chez les enfants présentant un trouble déficit de l’attention avec ou sans hyperactivité…
Solid Revenue Growth Coupled with High Gross Profit Margin (73%) and Non-IFRS Profit (RMB 376 Million) BEIJING, March 26, 2025 /PRNewswire/ — Bairong Inc. (the “Company”, “we” , “us” or “our” ; HKEX: 6608), a leading cloud-based AI turnkey service provider, today announced the…
NEW YORK, March 26, 2025 /PRNewswire/ — IMAGO Technologies, a leader in interactive technology solutions, today announced a suite of groundbreaking innovations poised to reshape how teams collaborate and learn. IMAGO’s latest updates set new standards for all-in-one smart board systems…
ISTANBUL, March 26, 2025 /PRNewswire/ — “Let warmth be within paw’s reach, let kindness connect us all.” On March 21, 2025, WePlay, a global leader in social entertainment, announced a philanthropic collaboration with the renowned stray animal rescue organization “Bakırköy City Street…
BEIJING, March 26, 2025 /PRNewswire/ — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Total…
BEIJING, March 26, 2025 /PRNewswire/ — Cheetah Mobile Inc. (NYSE: CMCM) (“Cheetah Mobile” or the “Company”), a China-based IT company, today announced its unaudited consolidated financial results for the quarter and fiscal year ended December 31, 2024. Management Commentary Mr. Sheng Fu,…
Pioneering cancer immunology company Asgard strengthens leadership team as it progresses its lead asset AT-108 towards clinical trials Shane brings over two decades of expertise in immunology-driven drug discovery with a specialized focus on novel modalities AT-108 is a first-in-class,…
SAN MATEO, Calif., March 26, 2025 /PRNewswire/ — Verkada, a pioneer in cloud-based physical security solutions, announced a new integration with SimonsVoss SmartIntego wireless locks at its VerkadaOne London conference. An extension of its flagship conference in the United States,…
SHANGHAI and HONG KONG, March 26, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines…